Stevanato Group S.p.A (STVN) Cash & Current Investments (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Cash & Current Investments of $143.0 million for Q1 2026, up 39.92% year-over-year from $102.2 million in Q1 2025, and down 13.14% quarter-over-quarter from $164.6 million in Q4 2025.
Stevanato Group S.p.A (STVN) Cash & Current Investments (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Cash & Current Investments for 7 consecutive years, with $143.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments rose 39.92% year-over-year to $143.0 million; the TTM figure through Mar 2026 stood at $143.0 million (up 39.92% YoY), while the FY2025 annual figure was $164.6 million, up 54.63% from the prior year.
- Cash & Current Investments declined to $143.0 million in Q1 2026 per STVN's latest filing, from $164.6 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $443.7 million in Q1 2022 and bottomed at $72.3 million in Q2 2023.
- Historically, Cash & Current Investments has averaged $173.7 million across 5 years, with a median of $141.6 million in 2025.
- Annual changes were most pronounced in 2022 — Cash & Current Investments soared 1149584.78% — and 2023, when it tumbled 80.41%.
- Stevanato Group S.p.A's Cash & Current Investments stood at $267.7 million in 2022, then plunged by 70.25% to $79.6 million in 2023, then soared by 33.67% to $106.4 million in 2024, then soared by 54.63% to $164.6 million in 2025, then fell by 13.14% to $143.0 million in 2026.
- Business Quant data shows STVN's Cash & Current Investments at $143.0 million in Q1 2026, $164.6 million in Q4 2025, and $141.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 863.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.68 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 108.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 108.02 Mn |
| Mar 31, 2026 | 142.95 Mn |
| Dec 31, 2025 | 164.57 Mn |
| Sep 30, 2025 | 141.56 Mn |
| Jun 30, 2025 | 120.76 Mn |
| Mar 31, 2025 | 102.16 Mn |
| Dec 31, 2024 | 106.43 Mn |
| Sep 30, 2024 | 88.56 Mn |
| Jun 30, 2024 | 86.65 Mn |
| Mar 31, 2024 | 206.04 Mn |
| Dec 31, 2023 | 79.62 Mn |
| Sep 30, 2023 | 73.18 Mn |
| Jun 30, 2023 | 72.26 Mn |
| Mar 31, 2023 | 191.93 Mn |
| Dec 31, 2022 | 267.65 Mn |
| Sep 30, 2022 | 295.78 Mn |
| Jun 30, 2022 | 368.95 Mn |
| Mar 31, 2022 | 443.70 Mn |
| Dec 31, 2021 | 501.33 Mn |
| Sep 30, 2021 | 537.07 Mn |